ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
64 028,04
0,21%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Panbela Therapeutics Inc (PBLA)

  7. Panbela Therapeutics Inc (PBLA) Actualités

PBLA Panbela Therapeutics Inc

1,11
0,00 (0,00%)
03 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Panbela Therapeutics Inc PBLA NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 1,11 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,11 1,11
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
01/5/202422:15GLOBEPanbela to Host First Quarter 2024 Earnings Conference Call..
30/4/202414:00GLOBEAcceptance of Eflornithine (DFMO) Abstract for Oral..
26/4/202422:39EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
25/4/202422:36EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
25/4/202422:35EDGAR2Form 8-K - Current report
25/4/202415:09EDGAR2Form 25-NSE - Notification filed by national security..
22/4/202414:02EDGAR2Form 8-K - Current report
22/4/202414:00GLOBEPanbela Therapeutics Announces Interim Data Analysis for..
18/4/202422:31EDGAR2Form S-1 - General form for registration of securities under..
18/4/202414:00GLOBEPanbela Announces Poster Presentation at American..
17/4/202414:36EDGAR2Form 8-K - Current report
17/4/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
16/4/202423:29GLOBEPanbela Announces Transfer to OTCQB Market
04/4/202422:17EDGAR2Form DEF 14A - Other definitive proxy statements
29/3/202422:24EDGAR2Form S-1 - General form for registration of securities under..
29/3/202422:08EDGAR2Form POS AM - Post-Effective amendments for registration..
26/3/202421:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
26/3/202421:12EDGAR2Form 8-K - Current report
26/3/202421:10GLOBEPanbela Provides Business Update and Reports Q4 and FY 2024..
26/3/202412:21IHMARKETNEWSU.S. Index Futures on the Rise, Oil Prices Show Stability
25/3/202421:15EDGAR2Form PRE 14A - Other preliminary proxy statements
12/3/202421:15GLOBEPanbela to Host Fourth Quarter and Year End 2023 Earnings..
07/3/202412:01EDGAR2Form 8-K - Current report
15/2/202414:05EDGAR2Form 8-K - Current report
15/2/202414:00GLOBEPanbela Regains Compliance with Nasdaq Listing Standards for..
14/2/202402:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202423:24EDGAR2Form 8-K - Current report
01/2/202413:15EDGAR2Form 8-K - Current report
01/2/202413:00GLOBEPanbela Announces Closing of Approximately $9.0 Million..
30/1/202423:28EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
30/1/202414:15GLOBEAcceptance of Ivospemin (SBP-101) Abstract for Poster..
29/1/202412:21EDGAR2Form 8-K - Current report
29/1/202412:15GLOBEPanbela Announces Pricing of Approximately $9.0 Million..
25/1/202418:22EDGAR2Form S-1/A - General form for registration of securities..
25/1/202414:54EDGAR2Form S-1/A - General form for registration of securities..
25/1/202413:00GLOBEPanbela Exceeds 50% Enrollment for Aspire Trial in..
22/1/202412:08EDGAR2Form S-1/A - General form for registration of securities..
19/1/202423:20EDGAR2Form 8-K - Current report
18/1/202414:15GLOBEPanbela Announces Publication of Clinical Data Titled: Phase..
16/1/202414:00GLOBEPanbela Announces 1-for-20 Reverse Stock Split Effective..
05/1/202422:34EDGAR2Form S-8 - Securities to be offered to employees in employee..
21/12/202315:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
21/12/202315:25EDGAR2Form 8-K - Current report
21/12/202315:15GLOBEPanbela Therapeutics Announces Exercise of Warrants and..
21/12/202312:00EDGAR2Form 8-K - Current report
18/12/202314:15GLOBEPanbela Therapeutics Announces US WorldMeds NDA Approval for..
04/12/202314:00GLOBEPanbela Announces Publication of Abstract Titled: Evaluation..
01/12/202322:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
01/12/202322:15EDGAR2Form 8-K - Current report
29/11/202314:15GLOBEPanbela Announces 2nd Independent Safety Review of the..

Dernières Valeurs Consultées

NASDAQ
PBLA
Panbela Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés